chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Myalgia
Clinical narrative: Chest pain; Chills; Body aches; This spontaneous case was reported by an other health care professional and describes the occurrence of CHEST PAIN (Chest pain), CHILLS (Chills) and MYALGIA (Body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain), CHILLS (Chills) and MYALGIA (Body aches). At the time of the report, CHEST PAIN (Chest pain), CHILLS (Chills) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: scalp numbness/numb face; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (scalp numbness/numb face) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0032b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced HYPOAESTHESIA (scalp numbness/numb face). At the time of the report, HYPOAESTHESIA (scalp numbness/numb face) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  Treatment medications were not provided..   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow up received on 23-JUN-2021 contains no significant information.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus
Clinical narrative: Itchiness; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness) and PAIN IN EXTREMITY (Arm pain) in a child male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-May-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 03-May-2021, the patient experienced PRURITUS (Itchiness). At the time of the report, PRURITUS (Itchiness) and PAIN IN EXTREMITY (Arm pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   ?No treatment information was provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: little soreness for day or two; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (little soreness for day or two) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, LEVOCETIRIZINE and SIMVASTATIN for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (little soreness for day or two). At the time of the report, PAIN (little soreness for day or two) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.    This case was linked to US-MODERNATX, INC.-MOD-2021-102790, US-MODERNATX, INC.-MOD-2021-041143, MOD21-086084 (E2B Linked Report). This case was linked to MOD-2021-103067 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-102790: US-MODERNATX, INC.-MOD-2021-041143: MOD21-086084:
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old received the first dose vaccine; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received the first dose vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received the first dose vaccine). On 04-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old received the first dose vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication were reported.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: Chills; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and MYALGIA (Sore arm) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills) and MYALGIA (Sore arm). At the time of the report, CHILLS (Chills) and MYALGIA (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided   This case was linked to US-MODERNATX, INC.-MOD-2021-103015 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-103015:Case for wife
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling face, Vision blurred
Clinical narrative: itching got worse after second vaccine; my face is swollen; eyes are blurry /  I could hardly read anything; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching got worse after second vaccine), SWELLING FACE (my face is swollen) and VISION BLURRED (eyes are blurry /  I could hardly read anything) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced SWELLING FACE (my face is swollen) and VISION BLURRED (eyes are blurry /  I could hardly read anything). On an unknown date, the patient experienced PRURITUS (itching got worse after second vaccine). At the time of the report, PRURITUS (itching got worse after second vaccine), SWELLING FACE (my face is swollen) and VISION BLURRED (eyes are blurry /  I could hardly read anything) outcome was unknown.            No concomitant medications were provided. No treatment drugs were reported.    This case was linked to MOD-2021-103048 (Patient Link).
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Product administered to patient of inappropriate age, Rash
Clinical narrative: my 17 year old patient was given vaccine 2 weeks ago; Blisters on arm; Rash on arm; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (my 17 year old patient was given vaccine 2 weeks ago), BLISTER (Blisters on arm) and RASH (Rash on arm) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (my 17 year old patient was given vaccine 2 weeks ago), BLISTER (Blisters on arm) and RASH (Rash on arm). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (my 17 year old patient was given vaccine 2 weeks ago), BLISTER (Blisters on arm) and RASH (Rash on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: she experienced a fever; muscle aches; nausea; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (she experienced a fever), MYALGIA (muscle aches), NAUSEA (nausea) and ARTHRALGIA (joint pain) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in February 2021.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced PYREXIA (she experienced a fever), MYALGIA (muscle aches), NAUSEA (nausea) and ARTHRALGIA (joint pain). At the time of the report, PYREXIA (she experienced a fever), MYALGIA (muscle aches), NAUSEA (nausea) and ARTHRALGIA (joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported No treatment medication was reported
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: little soreness for day or two; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (little soreness for day or two) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 012A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL, LEVOCETIRIZINE and SIMVASTATIN for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (little soreness for day or two). At the time of the report, PAIN (little soreness for day or two) outcome was unknown. Not Provided          No treatment information was provided.    This case was linked to MOD-2021-103056 (Patient Link).
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain at injection site left arm after first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection site left arm after first dose) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site left arm after first dose). At the time of the report, VACCINATION SITE PAIN (pain at injection site left arm after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided No treatment details were provided   This case was linked to MOD-2021-103086 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeling abnormal, Nausea, Pyrexia
Clinical narrative: diarrhea; mental fog like severe symptoms; fever (100+ degrees Fahrenheit); nausea; This spontaneous case was reported by a health care professional and describes the occurrence of DIARRHOEA (diarrhea), FEELING ABNORMAL (mental fog like severe symptoms), PYREXIA (fever (100+ degrees Fahrenheit)) and NAUSEA (nausea) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21ASJM-PMG and 027B21A) for COVID-19 vaccination.     The patient's past medical history included Surgery.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced DIARRHOEA (diarrhea), FEELING ABNORMAL (mental fog like severe symptoms), PYREXIA (fever (100+ degrees Fahrenheit)) and NAUSEA (nausea). The patient was treated with OXYCODONE at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Diarrhea, at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), FEELING ABNORMAL (mental fog like severe symptoms), PYREXIA (fever (100+ degrees Fahrenheit)) and NAUSEA (nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthma, Chills, Decreased appetite, Diarrhoea
Clinical narrative: Diarrhea; Feels like I have asthma/using inhaler more than I should; Night sweats; Chills; Soreness of left shoulder; Fever; Headache; Nausea; Loss of appetite; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), DIARRHOEA (Diarrhea), ASTHMA (Feels like I have asthma/using inhaler more than I should), NIGHT SWEATS (Night sweats) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A,) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma. Concomitant products included SALBUTAMOL (ALBUTEROL HFA) and GABAPENTIN for an unknown indication.    On 01-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced DECREASED APPETITE (Loss of appetite), CHILLS (Chills), ARTHRALGIA (Soreness of left shoulder), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea). On 02-May-2021, the patient experienced DIARRHOEA (Diarrhea), ASTHMA (Feels like I have asthma/using inhaler more than I should) and NIGHT SWEATS (Night sweats). On 02-May-2021, DIARRHOEA (Diarrhea), NIGHT SWEATS (Night sweats), CHILLS (Chills), ARTHRALGIA (Soreness of left shoulder), HEADACHE (Headache) and NAUSEA (Nausea) had resolved. At the time of the report, DECREASED APPETITE (Loss of appetite), ASTHMA (Feels like I have asthma/using inhaler more than I should) and PYREXIA (Fever) outcome was unknown.            No laboratory details were  provided. Treatment medication included Aspirin 81 mg.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Night sweats, Pyrexia
Clinical narrative: Diarrhea; Feels like I have asthma/using inhaler more than I should; Night sweats; Chills; Soreness of left shoulder; Fever; Headache; Nausea; Loss of appetite; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), DIARRHOEA (Diarrhea), ASTHMA (Feels like I have asthma/using inhaler more than I should), NIGHT SWEATS (Night sweats) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A,) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma. Concomitant products included SALBUTAMOL (ALBUTEROL HFA) and GABAPENTIN for an unknown indication.    On 01-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced DECREASED APPETITE (Loss of appetite), CHILLS (Chills), ARTHRALGIA (Soreness of left shoulder), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea). On 02-May-2021, the patient experienced DIARRHOEA (Diarrhea), ASTHMA (Feels like I have asthma/using inhaler more than I should) and NIGHT SWEATS (Night sweats). On 02-May-2021, DIARRHOEA (Diarrhea), NIGHT SWEATS (Night sweats), CHILLS (Chills), ARTHRALGIA (Soreness of left shoulder), HEADACHE (Headache) and NAUSEA (Nausea) had resolved. At the time of the report, DECREASED APPETITE (Loss of appetite), ASTHMA (Feels like I have asthma/using inhaler more than I should) and PYREXIA (Fever) outcome was unknown.            No laboratory details were  provided. Treatment medication included Aspirin 81 mg.  Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Influenza like illness
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of influenza-like illness (flu-like symptoms), asthenia (in bed for one whole day) and fatigue (extreme tiredness for about 3-4 days) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 038K20A) for COVID-19 immunization. No medical history reported. On Mar 25, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced influenza-like illness (flu-like symptoms), asthenia (in bed for one whole day) and fatigue (extreme tiredness for about 3-4 days). At the time of the report, influenza-like illness (flu-like symptoms), asthenia (in bed for one whole day) and fatigue (extreme tiredness for about 3-4 days) outcome: unknown/not provided The reporter did not provide any causality assessments. Treatment: Tylenol- didn't help. Concomitant product details not provided. This case linked to MOD-2021-039893 (patient link).
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and HEADACHE (Mild headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. No Medical History information was reported. On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and HEADACHE (Mild headache). At the time of the report, PAIN IN EXTREMITY (sore arm) and HEADACHE (Mild headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pityriasis rosea, Rash, SARS-CoV-2 test, Type IV hypersensitivity reaction
Clinical narrative: Pityriasis rosea; rash all over upper from neck to waist; COVID arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PITYRIASIS ROSEA (Pityriasis rosea), TYPE IV HYPERSENSITIVITY REACTION (COVID arm at the injection site) and RASH (rash all over upper from neck to waist) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE for Reflux gastritis, COLECALCIFEROL (VITAMIN D 3) for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (COVID arm at the injection site). On 24-Apr-2021, the patient experienced RASH (rash all over upper from neck to waist). On 03-May-2021, the patient experienced PITYRIASIS ROSEA (Pityriasis rosea). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at a dose of 10 mg once a day and TRIAMCINOLONE ACETONIDE at an unspecified dose and frequency. At the time of the report, PITYRIASIS ROSEA (Pityriasis rosea) and RASH (rash all over upper from neck to waist) outcome was unknown and TYPE IV HYPERSENSITIVITY REACTION (COVID arm at the injection site) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Apr-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       laboratory test details include Strep throat test was negative On 28Apr2021,
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash papular, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: itchiness; white raised bumps; redness in her injection arm; swelling in her injection arm; injection site was warm to the touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site was warm to the touch), PRURITUS (itchiness), RASH PAPULAR (white raised bumps), VACCINATION SITE ERYTHEMA (redness in her injection arm) and VACCINATION SITE SWELLING (swelling in her injection arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced VACCINATION SITE WARMTH (injection site was warm to the touch), VACCINATION SITE ERYTHEMA (redness in her injection arm) and VACCINATION SITE SWELLING (swelling in her injection arm). On 03-May-2021, the patient experienced PRURITUS (itchiness) and RASH PAPULAR (white raised bumps). At the time of the report, VACCINATION SITE WARMTH (injection site was warm to the touch), PRURITUS (itchiness), RASH PAPULAR (white raised bumps), VACCINATION SITE ERYTHEMA (redness in her injection arm) and VACCINATION SITE SWELLING (swelling in her injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Relevant concomitant medications was reported.  Treatment information was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on upper part of body, back, face; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on upper part of body, back, face) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash on upper part of body, back, face). At the time of the report, RASH (rash on upper part of body, back, face) outcome was unknown. Not Provided          No concomitant and treatment medications were reported.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: swelling knot left; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling knot left) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 039A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-May-2021, the patient experienced VACCINATION SITE SWELLING (swelling knot left). At the time of the report, VACCINATION SITE SWELLING (swelling knot left) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable. Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-103072 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pain, Swelling
Clinical narrative: Sharp pain shooting through arm; The arm is also swollen; She started breaking out in the arm in which she received the vaccine, the arm was all red with itching; She started breaking out in the arm in which she received the vaccine, the arm was all red with itching; She started breaking out in the arm in which she received the vaccine, the arm was all red with itching; Fatigue; Chills; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Sharp pain shooting through arm), SWELLING (The arm is also swollen), VACCINATION SITE PRURITUS (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching), FATIGUE (Fatigue) and CHILLS (Chills) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for Blood disorder.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced FATIGUE (Fatigue), CHILLS (Chills) and MYALGIA (Soreness). On 30-Apr-2021, the patient experienced PAIN (Sharp pain shooting through arm), SWELLING (The arm is also swollen), VACCINATION SITE PRURITUS (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching), VACCINATION SITE RASH (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching) and VACCINATION SITE ERYTHEMA (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching). At the time of the report, PAIN (Sharp pain shooting through arm), SWELLING (The arm is also swollen), VACCINATION SITE PRURITUS (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching), FATIGUE (Fatigue), CHILLS (Chills), MYALGIA (Soreness), VACCINATION SITE RASH (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching) and VACCINATION SITE ERYTHEMA (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included anti-itch cream on arm.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Sharp pain shooting through arm; The arm is also swollen; She started breaking out in the arm in which she received the vaccine, the arm was all red with itching; She started breaking out in the arm in which she received the vaccine, the arm was all red with itching; She started breaking out in the arm in which she received the vaccine, the arm was all red with itching; Fatigue; Chills; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Sharp pain shooting through arm), SWELLING (The arm is also swollen), VACCINATION SITE PRURITUS (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching), FATIGUE (Fatigue) and CHILLS (Chills) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for Blood disorder.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, the patient experienced FATIGUE (Fatigue), CHILLS (Chills) and MYALGIA (Soreness). On 30-Apr-2021, the patient experienced PAIN (Sharp pain shooting through arm), SWELLING (The arm is also swollen), VACCINATION SITE PRURITUS (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching), VACCINATION SITE RASH (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching) and VACCINATION SITE ERYTHEMA (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching). At the time of the report, PAIN (Sharp pain shooting through arm), SWELLING (The arm is also swollen), VACCINATION SITE PRURITUS (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching), FATIGUE (Fatigue), CHILLS (Chills), MYALGIA (Soreness), VACCINATION SITE RASH (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching) and VACCINATION SITE ERYTHEMA (She started breaking out in the arm in which she received the vaccine, the arm was all red with itching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included anti-itch cream on arm.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Eye pain, Fatigue
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (all the side effects), MOTION SICKNESS (Motion sickness), VERTIGO (Vertigo), EYE PAIN (Eyes hurt) and DIZZINESS (Felt dizzy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 032B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Vestibular nerve damage (vestibular nerve damage in the ears) since an unknown date. Previously administered products included for Product used for unknown indication: Levaquin. Past adverse reactions to the above products included Tremor with Levaquin. Concurrent medical conditions included Vertigo (Patient states that Vertigo attacks are on/off prior to Moderna vaccine doses) and Hypothyroidism (No recent change.). Concomitant products included LEVOTHYROXINE, FISH OIL, CENTRUM SILVER +50, D-MANNOSE, VACCINIUM MACROCARPON (CRANBERRY D) and VITAMIN D3 for an unknown indication.   On 01-Apr-2021 at 10:10 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021 at 10:12 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced VACCINATION COMPLICATION (all the side effects), MOTION SICKNESS (Motion sickness), EYE PAIN (Eyes hurt), NECK PAIN (pain in neck), RASH (rash in the right arm), ARTHRALGIA (Pain in shoulder), NAUSEA (Slight nausea) and HEADACHE (Bad headache, pain in back of the head,). On 03-May-2021, the patient experienced VERTIGO (Vertigo). On 04-May-2021, the patient experienced DIZZINESS (Felt dizzy) and FATIGUE (tired). On an unknown date, the patient experienced HYPERHIDROSIS (Sweating), MYALGIA (Muscle ache), CHILLS (chills) and PYREXIA (fever). The patient was treated with MECLOZINE HYDROCHLORIDE (BONINE) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 01-May-2021, VACCINATION COMPLICATION (all the side effects), MOTION SICKNESS (Motion sickness), EYE PAIN (Eyes hurt), NECK PAIN (pain in neck), HYPERHIDROSIS (Sweating), RASH (rash in the right arm), ARTHRALGIA (Pain in shoulder), NAUSEA (Slight nausea), HEADACHE (Bad headache, pain in back of the head,), MYALGIA (Muscle ache), CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, VERTIGO (Vertigo), DIZZINESS (Felt dizzy) and FATIGUE (tired) had resolved.            Treatment drug included Tylenol. Patient experienced side effects from Cipro (Nausea) and no allergic reaction.   This case was linked to US-MODERNATX, INC.-MOD-2021-103068 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Concomitant medications updated. Outcome of events updated. Stop date of events updated. Events updated. Patient details are updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-103068:First Dose Case
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Motion sickness, Myalgia, Nausea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (all the side effects), MOTION SICKNESS (Motion sickness), VERTIGO (Vertigo), EYE PAIN (Eyes hurt) and DIZZINESS (Felt dizzy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 032B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Vestibular nerve damage (vestibular nerve damage in the ears) since an unknown date. Previously administered products included for Product used for unknown indication: Levaquin. Past adverse reactions to the above products included Tremor with Levaquin. Concurrent medical conditions included Vertigo (Patient states that Vertigo attacks are on/off prior to Moderna vaccine doses) and Hypothyroidism (No recent change.). Concomitant products included LEVOTHYROXINE, FISH OIL, CENTRUM SILVER +50, D-MANNOSE, VACCINIUM MACROCARPON (CRANBERRY D) and VITAMIN D3 for an unknown indication.   On 01-Apr-2021 at 10:10 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021 at 10:12 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced VACCINATION COMPLICATION (all the side effects), MOTION SICKNESS (Motion sickness), EYE PAIN (Eyes hurt), NECK PAIN (pain in neck), RASH (rash in the right arm), ARTHRALGIA (Pain in shoulder), NAUSEA (Slight nausea) and HEADACHE (Bad headache, pain in back of the head,). On 03-May-2021, the patient experienced VERTIGO (Vertigo). On 04-May-2021, the patient experienced DIZZINESS (Felt dizzy) and FATIGUE (tired). On an unknown date, the patient experienced HYPERHIDROSIS (Sweating), MYALGIA (Muscle ache), CHILLS (chills) and PYREXIA (fever). The patient was treated with MECLOZINE HYDROCHLORIDE (BONINE) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 01-May-2021, VACCINATION COMPLICATION (all the side effects), MOTION SICKNESS (Motion sickness), EYE PAIN (Eyes hurt), NECK PAIN (pain in neck), HYPERHIDROSIS (Sweating), RASH (rash in the right arm), ARTHRALGIA (Pain in shoulder), NAUSEA (Slight nausea), HEADACHE (Bad headache, pain in back of the head,), MYALGIA (Muscle ache), CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, VERTIGO (Vertigo), DIZZINESS (Felt dizzy) and FATIGUE (tired) had resolved.            Treatment drug included Tylenol. Patient experienced side effects from Cipro (Nausea) and no allergic reaction.   This case was linked to US-MODERNATX, INC.-MOD-2021-103068 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Concomitant medications updated. Outcome of events updated. Stop date of events updated. Events updated. Patient details are updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-103068:First Dose Case
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pyrexia, Rash, Vaccination complication, Vertigo
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (all the side effects), MOTION SICKNESS (Motion sickness), VERTIGO (Vertigo), EYE PAIN (Eyes hurt) and DIZZINESS (Felt dizzy) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048B21A and 032B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Vestibular nerve damage (vestibular nerve damage in the ears) since an unknown date. Previously administered products included for Product used for unknown indication: Levaquin. Past adverse reactions to the above products included Tremor with Levaquin. Concurrent medical conditions included Vertigo (Patient states that Vertigo attacks are on/off prior to Moderna vaccine doses) and Hypothyroidism (No recent change.). Concomitant products included LEVOTHYROXINE, FISH OIL, CENTRUM SILVER +50, D-MANNOSE, VACCINIUM MACROCARPON (CRANBERRY D) and VITAMIN D3 for an unknown indication.   On 01-Apr-2021 at 10:10 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021 at 10:12 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Apr-2021, the patient experienced VACCINATION COMPLICATION (all the side effects), MOTION SICKNESS (Motion sickness), EYE PAIN (Eyes hurt), NECK PAIN (pain in neck), RASH (rash in the right arm), ARTHRALGIA (Pain in shoulder), NAUSEA (Slight nausea) and HEADACHE (Bad headache, pain in back of the head,). On 03-May-2021, the patient experienced VERTIGO (Vertigo). On 04-May-2021, the patient experienced DIZZINESS (Felt dizzy) and FATIGUE (tired). On an unknown date, the patient experienced HYPERHIDROSIS (Sweating), MYALGIA (Muscle ache), CHILLS (chills) and PYREXIA (fever). The patient was treated with MECLOZINE HYDROCHLORIDE (BONINE) ongoing since an unknown date for Adverse event, at an unspecified dose and frequency. On 01-May-2021, VACCINATION COMPLICATION (all the side effects), MOTION SICKNESS (Motion sickness), EYE PAIN (Eyes hurt), NECK PAIN (pain in neck), HYPERHIDROSIS (Sweating), RASH (rash in the right arm), ARTHRALGIA (Pain in shoulder), NAUSEA (Slight nausea), HEADACHE (Bad headache, pain in back of the head,), MYALGIA (Muscle ache), CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, VERTIGO (Vertigo), DIZZINESS (Felt dizzy) and FATIGUE (tired) had resolved.            Treatment drug included Tylenol. Patient experienced side effects from Cipro (Nausea) and no allergic reaction.   This case was linked to US-MODERNATX, INC.-MOD-2021-103068 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Concomitant medications updated. Outcome of events updated. Stop date of events updated. Events updated. Patient details are updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-103068:First Dose Case
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: the inside top roof of the mouth went numb, and then the nose and kind of under the eyes, described as the bridge of the face, went numb; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (the inside top roof of the mouth went numb, and then the nose and kind of under the eyes, described as the bridge of the face, went numb) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced HYPOAESTHESIA (the inside top roof of the mouth went numb, and then the nose and kind of under the eyes, described as the bridge of the face, went numb). At the time of the report, HYPOAESTHESIA (the inside top roof of the mouth went numb, and then the nose and kind of under the eyes, described as the bridge of the face, went numb) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No laboratory details were  provided. No treatment medications were reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Nausea
Clinical narrative: Diarrhea; lightheadedness; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DIZZINESS (lightheadedness) and NAUSEA (nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031821A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (lightheadedness) and NAUSEA (nausea). On 28-Apr-2021, the patient experienced DIARRHOEA (Diarrhea). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency and BISMUTH SUBSALICYLATE (PEPTOBISMOL) at an unspecified dose and frequency. On 07-Apr-2021, DIZZINESS (lightheadedness) and NAUSEA (nausea) had resolved. At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication reported   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: non significant follow up was received on 04-jun-2021 no new information updated.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Influenza like illness, Myalgia, Sluggishness
Clinical narrative: flu like symptoms; bodyaches; sluggish; sore body; headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (bodyaches), SLUGGISHNESS (sluggish), ARTHRALGIA (sore body) and HEADACHE (headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included COPD.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced HEADACHE (headache). On 03-May-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (bodyaches), SLUGGISHNESS (sluggish) and ARTHRALGIA (sore body). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), MYALGIA (bodyaches), SLUGGISHNESS (sluggish), ARTHRALGIA (sore body) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment details were provided.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (ANTIHISTAMINE ALLERGY RELIEF) and LANSOPRAZOLE for an unknown indication. On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. No treatment medication was reported. This case was linked to MOD-2021-103184.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Antibody test, Chills, Dyspnoea, Fatigue
Clinical narrative: To top it off my hair started falling out by the handfuls; tire quickly.; trouble breathing; fever; Severe headache like migraine; nausea; chills; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (trouble breathing), ALOPECIA (To top it off my hair started falling out by the handfuls), HEADACHE (Severe headache like migraine), NAUSEA (nausea) and CHILLS (chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in February 2021. Concomitant products included LOSARTAN, OMEPRAZOLE, ROSUVASTATIN, GABAPENTIN, LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL), UBIDECARENONE (COQ) and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced CHILLS (chills). On 28-Apr-2021, the patient experienced DYSPNOEA (trouble breathing), HEADACHE (Severe headache like migraine), NAUSEA (nausea) and PYREXIA (fever). On an unknown date, the patient experienced ALOPECIA (To top it off my hair started falling out by the handfuls) and FATIGUE (tire quickly.). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 29-Apr-2021, HEADACHE (Severe headache like migraine), CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, DYSPNOEA (trouble breathing) and NAUSEA (nausea) had not resolved and ALOPECIA (To top it off my hair started falling out by the handfuls) and FATIGUE (tire quickly.) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Antibody test: other (High) high.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Added two additional events fatigue and alopecia.